Your browser is no longer supported. Please, upgrade your browser.
Settings
ORIC [NASD]
ORIC Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-2.70 Insider Own0.10% Shs Outstand36.70M Perf Week-8.19%
Market Cap591.98M Forward P/E- EPS next Y-2.88 Insider Trans-57.02% Shs Float25.42M Perf Month-38.93%
Income-91.30M PEG- EPS next Q-0.58 Inst Own96.60% Short Float11.84% Perf Quarter-10.72%
Sales- P/S- EPS this Y-244.10% Inst Trans0.20% Short Ratio11.08 Perf Half Y-39.06%
Book/sh7.04 P/B2.12 EPS next Y-27.90% ROA-35.00% Target Price- Perf Year-26.67%
Cash/sh6.57 P/C2.27 EPS next 5Y- ROE-36.20% 52W Range11.91 - 40.81 Perf YTD-55.98%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-63.49% Beta-
Dividend %- Quick Ratio26.80 Sales past 5Y- Gross Margin- 52W Low25.10% ATR1.45
Employees70 Current Ratio26.80 Sales Q/Q- Oper. Margin- RSI (14)33.86 Volatility5.57% 9.71%
OptionableYes Debt/Eq0.00 EPS Q/Q-55.40% Profit Margin- Rel Volume0.59 Prev Close15.11
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume271.56K Price14.90
Recom1.30 SMA20-16.85% SMA50-27.52% SMA200-37.34% Volume160,583 Change-1.39%
Jul-06-21Upgrade Citigroup Neutral → Buy $34
Jan-25-21Downgrade Citigroup Buy → Neutral $34
Aug-13-20Initiated Robert W. Baird Outperform $45
Aug-06-20Upgrade Citigroup Neutral → Buy $35
Aug-03-20Initiated H.C. Wainwright Buy $52
May-19-20Initiated JP Morgan Overweight $40
May-19-20Initiated Jefferies Buy $40
May-19-20Initiated Guggenheim Buy $45
May-19-20Initiated Citigroup Neutral $35
Oct-11-21 04:24AM  
Oct-07-21 03:12PM  
12:28PM  
10:16AM  
08:55AM  
Sep-30-21 04:30PM  
Sep-21-21 08:42AM  
06:30AM  
Sep-17-21 10:36AM  
Sep-01-21 08:00AM  
Aug-16-21 04:15PM  
Aug-10-21 04:05PM  
Aug-02-21 08:40AM  
Jun-28-21 08:00AM  
Jun-03-21 08:22AM  
Jun-02-21 04:55PM  
May-26-21 04:30PM  
May-25-21 08:00AM  
May-06-21 04:05PM  
Apr-28-21 04:05PM  
Apr-12-21 06:30AM  
Mar-23-21 04:05PM  
Mar-10-21 04:30PM  
Mar-02-21 06:30AM  
Feb-17-21 12:15PM  
Feb-03-21 04:30PM  
Feb-02-21 04:04AM  
Jan-11-21 06:30AM  
Jan-08-21 10:35AM  
Jan-04-21 06:30AM  
Dec-21-20 06:30AM  
Dec-10-20 04:50PM  
Dec-01-20 08:30AM  
Nov-17-20 04:15PM  
Nov-13-20 06:32AM  
Nov-10-20 04:05PM  
Nov-09-20 06:30AM  
Nov-05-20 04:05PM  
Nov-04-20 10:43AM  
Oct-19-20 04:02PM  
Oct-09-20 06:30AM  
Sep-02-20 04:30PM  
Aug-06-20 03:50PM  
Aug-05-20 04:10PM  
04:05PM  
Aug-03-20 10:15PM  
Jun-22-20 09:00AM  
Jun-09-20 04:15PM  
May-27-20 06:30AM  
May-26-20 06:30AM  
May-20-20 04:15PM  
Apr-28-20 04:30PM  
Apr-27-20 04:30PM  
Apr-23-20 08:56PM  
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers. The company's lead product candidate is ORIC-101, a small molecule antagonist of the glucocorticoid receptor, which has been linked to resistance to multiple classes of cancer therapeutics across various solid tumors. Its other product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens; ORIC-944, an allosteric inhibitor for prostate cancer; and ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations. The company is also developing multiple precision medicines targeting other cancer resistance mechanisms. It has collaboration and license agreement with Astellas Pharma, Inc.; Voronoi, Inc.; and Mirati Therapeutics, Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Heyman Richard A.DirectorSep 15Sale25.0368217,074216,272Sep 16 06:19 PM
Chacko JacobPresident and CEOSep 15Sale25.063,73693,6292,652Sep 16 06:17 PM
Chacko JacobPresident and CEOSep 14Sale25.054,420110,7066,388Sep 16 06:17 PM
Heyman Richard A.DirectorSep 14Sale25.0570617,686216,954Sep 16 06:19 PM
Chacko JacobPresident and CEOSep 13Sale25.022,80170,08910,808Sep 14 04:01 PM
Heyman Richard A.DirectorSep 13Sale25.0160115,033217,660Sep 14 04:03 PM
Heyman Richard A.DirectorSep 10Sale25.1047912,023218,261Sep 14 04:03 PM
Chacko JacobPresident and CEOSep 10Sale25.082,94273,78313,609Sep 14 04:01 PM
Chacko JacobPresident and CEOSep 08Sale25.042005,00716,551Sep 09 04:33 PM
Heyman Richard A.DirectorSep 07Sale25.111,08627,272218,740Sep 09 04:36 PM
Chacko JacobPresident and CEOSep 07Sale25.115,981150,17316,751Sep 09 04:33 PM
Chacko JacobPresident and CEOMay 24Sale25.001230023,132May 24 07:27 PM
SCHELLER RICHARD HDirectorMay 24Sale25.001002,50039,092May 24 07:29 PM
Heyman Richard A.DirectorMay 24Sale25.001002,500219,826May 24 07:30 PM
Heyman Richard A.DirectorMay 21Sale25.2560015,150219,926May 24 07:30 PM
SCHELLER RICHARD HDirectorMay 21Sale25.191,23131,00839,192May 24 07:29 PM
Chacko JacobPresident and CEOMay 21Sale25.204,790120,68823,144May 24 07:27 PM
Chacko JacobPresident and CEOMay 20Sale25.072,46861,86427,934May 24 07:27 PM
SCHELLER RICHARD HDirectorMay 20Sale25.0865916,52840,423May 24 07:29 PM
Heyman Richard A.DirectorMay 20Sale25.0870017,558220,526May 24 07:30 PM
SCHELLER RICHARD HDirectorMay 18Sale25.342,80070,95841,082May 18 08:20 PM
Heyman Richard A.DirectorMay 18Sale25.322,16154,715221,226May 18 08:22 PM
Heyman Richard A.DirectorMay 17Sale25.0749812,484223,387May 18 08:22 PM
SCHELLER RICHARD HDirectorMay 17Sale25.0650012,53043,882May 18 08:20 PM
SCHELLER RICHARD HDirectorMay 14Sale25.384,615117,11744,382May 18 08:20 PM
Heyman Richard A.DirectorMay 14Sale25.313,21581,382223,885May 18 08:22 PM
SCHELLER RICHARD HDirectorMay 13Sale25.001002,50048,997May 13 07:59 PM
Chacko JacobPresident and CEOMay 13Sale25.0473018,28158,180May 13 07:57 PM
Chacko JacobPresident and CEOMay 12Sale25.0240010,01058,910May 13 07:57 PM
SCHELLER RICHARD HDirectorMay 12Sale25.001032,57549,097May 13 07:59 PM
Heyman Richard A.DirectorMay 11Sale25.111002,511227,100May 13 08:00 PM
SCHELLER RICHARD HDirectorMay 11Sale25.163007,54849,200May 13 07:59 PM
Chacko JacobPresident and CEOMay 11Sale25.221,09027,49059,310May 13 07:57 PM
Heyman Richard A.DirectorApr 30Sale25.261002,526227,200Apr 30 07:59 PM
Chacko JacobPresident and CEOApr 30Sale25.2460015,14360,400Apr 30 07:56 PM
SCHELLER RICHARD HDirectorApr 30Sale25.191002,51949,500Apr 30 07:57 PM
SCHELLER RICHARD HDirectorApr 28Sale25.112005,02249,600Apr 30 07:57 PM
Chacko JacobPresident and CEOApr 28Sale25.0670017,54261,000Apr 30 07:56 PM
Heyman Richard A.DirectorApr 28Sale25.081002,508227,300Apr 30 07:59 PM
SCHELLER RICHARD HDirectorApr 01Sale25.002005,00049,800Apr 05 07:45 PM
Heyman Richard A.DirectorApr 01Sale25.001002,500227,400Apr 05 07:42 PM
Chacko JacobPresident and CEOApr 01Sale25.0980020,07061,700Apr 05 07:40 PM
ORBIMED ADVISORS LLCDirectorMar 30Sale23.9327,869666,9052,212,571Mar 31 05:08 PM
GORDON CARL LDirectorMar 30Sale23.9327,869666,9052,212,571Mar 31 05:11 PM
GORDON CARL LDirectorMar 29Sale23.3175,5551,761,1872,240,440Mar 31 05:11 PM
ORBIMED ADVISORS LLCDirectorMar 29Sale23.3175,5551,761,1872,240,440Mar 31 05:08 PM
ORBIMED ADVISORS LLCDirectorMar 26Sale23.8827,816664,2462,315,995Mar 26 05:51 PM
GORDON CARL LDirectorMar 26Sale23.8827,816664,2462,315,995Mar 26 05:46 PM
GORDON CARL LDirectorMar 25Sale24.7051,5231,272,6182,343,811Mar 26 05:46 PM
ORBIMED ADVISORS LLCDirectorMar 25Sale24.7051,5231,272,6182,343,811Mar 26 05:51 PM
ORBIMED ADVISORS LLCDirectorMar 24Sale24.8032,959817,3832,395,334Mar 26 05:51 PM
GORDON CARL LDirectorMar 24Sale24.8032,959817,3832,395,334Mar 26 05:46 PM
GORDON CARL LDirectorMar 23Sale24.323,99297,0852,428,293Mar 23 05:26 PM
ORBIMED ADVISORS LLCDirectorMar 23Sale24.323,99297,0852,428,293Mar 23 05:22 PM
ORBIMED ADVISORS LLCDirectorMar 22Sale26.477,673203,1042,432,285Mar 23 05:22 PM
GORDON CARL LDirectorMar 22Sale26.477,673203,1042,432,285Mar 23 05:26 PM
GORDON CARL LDirectorMar 19Sale26.4721,275563,1492,439,958Mar 23 05:26 PM
ORBIMED ADVISORS LLCDirectorMar 19Sale26.4721,275563,1492,439,958Mar 23 05:22 PM
GORDON CARL LDirectorMar 18Sale28.036,059169,8342,461,233Mar 18 09:04 PM
ORBIMED ADVISORS LLCDirectorMar 18Sale28.036,059169,8342,461,233Mar 18 09:07 PM
ORBIMED ADVISORS LLCDirectorMar 17Sale28.4318,790534,2002,467,292Mar 18 09:07 PM
GORDON CARL LDirectorMar 17Sale28.4318,790534,2002,467,292Mar 18 09:04 PM
GORDON CARL LDirectorMar 16Sale27.7241,3531,146,3052,486,082Mar 18 09:04 PM
ORBIMED ADVISORS LLCDirectorMar 16Sale27.7241,3531,146,3052,486,082Mar 18 09:07 PM
GORDON CARL LDirectorMar 15Sale29.1489,2102,599,5792,527,435Mar 15 08:50 PM
ORBIMED ADVISORS LLCDirectorMar 15Sale29.1489,2102,599,5792,527,435Mar 15 08:55 PM
ORBIMED ADVISORS LLCDirectorMar 12Sale30.2990,5212,741,8812,616,645Mar 15 08:55 PM
GORDON CARL LDirectorMar 12Sale30.2990,5212,741,8812,616,645Mar 15 08:50 PM
GORDON CARL LDirectorMar 11Sale33.0458,5511,934,5252,707,166Mar 15 08:50 PM
ORBIMED ADVISORS LLCDirectorMar 11Sale33.0458,5511,934,5252,707,166Mar 15 08:55 PM